TW201529108A - Chemical volatilization bag and chemical volatilization container accommodating same - Google Patents

Abstract

To improve the degree of freedom of selection when using volatile chemicals such as air fresheners or deodorants. The present invention is provided with a soft inner-side bag body (12) formed of a gas-impermeable film (14) and having a volatile chemical (15) sealed therein, and a soft outer-side bag body (13) for accommodating the inner-side bag body (12). The inner-side bag body (12) is configured to be tearable as a result of the interior pressure being increased by an external force, the outer-side bag body (13) has one surface and another surface facing same, at least one of the surfaces being composed of a microporous sheet (17) having a plurality of micropores through which the volatile chemical (15) can infiltrate.

Description

Pharmacy volatile bag and medicament volatile container containing the same

The present invention relates to a drug volatilization bag that volatilizes a volatile drug such as a fragrance or a deodorant, and a drug volatilization container that accommodates the same.

For example, as disclosed in Patent Document 1, as a fragrance for diffusing a fragrance or a deodorant in a room or the like.

The fragrance packaging system disclosed in Patent Document 1 has heat sealability on the inner surface thereof, and includes a multilayer film having a gas barrier film layer, and seals the open end portion to forcefully press the contents with easy peeling strength. The bag can be easily unpacked to fill the sealed bag with a volatile fragrance, and the inner packaging bag sealed with the fragrance is sealed with a bag containing the gas permeable film. Refer to Figure 2 of Patent Document 1.

When the fragrance package is used, the inner packaging bag is pressed from the outer packaging bag, and the internal pressure is increased by the external force to unseal the sealing portion of the inner packaging bag, and the fragrance flows out to The outer packaging is inside the bag. Since the outer packaging bag is formed of a gas permeable film, the fragrance flowing out into the outer packaging bag is volatilized to the outside through the gas permeable film.

[Previous Technical Literature] [Patent Literature]

[Patent Document 1] Japanese Patent Publication No. 60-1730

However, in the fragrance package disclosed in Patent Document 1, since the fragrance is volatilized toward the outside of the outer bag, the gas permeable film is used to form both sides of the outer bag. However, depending on the kind of the fragrance, there is a case where it is difficult to volatilize the fragrance from the outer package bag. Specifically, the gas permeable film such as polyethylene has a poor permeability to alcohol such as linalool or dihydrogeranol which is a main component of the fragrance constituting the fragrance, and is restricted from volatilization.

That is, the fragrance used in the fragrance has a plurality of components and also involves various chemical properties. Further, the gas permeable film constituting the outer packaging bag also has different gas permeability depending on the material thereof. Therefore, in order to make the fragrance and the gas permeable film have good conformability, it is necessary to select a combination of a fragrance which can volatilize the fragrance from the outer packaging bag and the gas permeable film. Therefore, there is a problem that the fragrance which can be used for the gas permeable film constituting the outer bag is limited.

Therefore, the present invention has been made in view of the above problems, and an object of the present invention is to provide a drug volatile bag which can improve the selective elasticity of a volatile agent such as a fragrance or a deodorant, and a drug volatilization container which accommodates the same.

As a technical means for achieving the above object, the drug volatile bag of the present invention comprises: a soft inner bag body formed of a non-gas permeable film, which is filled with a volatile agent inside; and a soft outer side bag body, which is accommodated The inner bag body; the inner bag system is configured to be unsealed by raising an internal pressure by an external force, and the outer bag body has one side and the other side opposite thereto, and at least one side is provided with a majority of the volatile agent infiltration. The microporous sheet of pores is composed.

Here, the microporous sheet constituting at least one side of the outer bag body means a degree different from the gas permeable film which permeates the gas of the volatile drug at the molecular level, but is such that the volatile agent is wetted and oozes to the surface of the sheet. Physically formed with a plurality of micropores. also, The other side of the outer bag may be formed of a sheet which is incapable of infiltrating a volatile drug, in addition to the above-described microporous sheet. As the sheet which does not infiltrate the volatile agent, a gas permeable film which transmits a gas of a volatile drug at a molecular level or a non-gas permeable film which blocks a gas of a volatile agent can be applied. Thus, the material of the sheet constituting the other side of the outer bag body is arbitrary.

In the drug volatile bag of the present invention, when the inner bag is unsealed due to an increase in internal pressure due to an external force, the volatile agent sealed in the inner bag flows out into the outer bag. The outer bag system is composed of at least one side of a microporous sheet having a plurality of micropores for infiltrating the volatile agent, so that the volatile agent flowing out into the outer bag is infiltrated by the micropores of the microporous sheet and exuded to the sheet. The surface is volatilized to the outside.

In this way, the microporous sheet constituting at least one side of the outer bag body is formed by physically infiltrating a plurality of micropores to the extent that the volatile agent is wetted and oozes out to the surface of the sheet, and thus unlike the conventional gas permeable film, it is not necessary to select In combination with volatile agents involving a variety of chemical properties, a variety of volatile agents can be used to allow volatile agents to readily volatilize from the outer bag. As described above, since the microporous sheet constituting at least one side of the outer bag body is not limited to the volatile agent that can be used, the selective elasticity can be improved when the volatile agent is used.

Since the microporous sheet is impregnated with a plurality of micropores for the volatile agent and oozes to the surface of the sheet, the volatile amount of the volatile agent is also increased as compared with the gas permeable sheet, and the volatile agent can be made from the outer bag. The body volatilizes well. Therefore, it is not necessary to form both sides of the outer bag body with the microporous sheet, and it is only necessary to form at least one side of the outer bag body with the microporous sheet.

Further, the drug volatilization container according to the present invention is characterized in that the drug volatilization bag is housed, and a casing that is provided with a pressing portion that provides an external force to the inner bag body via the outer bag body is provided at a portion corresponding to the inner bag body. In the drug volatilization container, it is preferable to arrange the drug volatilization bag with one side of the outer bag body facing the upper side of the microporous sheet. The case is mounted to the mounted member.

When the drug volatilization container of the present invention is used, the drug volatilization bag housed in the outer casing is press-fitted into the pressing portion of the outer casing, whereby the outer bag body is provided with an external force to the inner bag body via the outer bag of the drug volatilization bag. By applying the external force, the internal pressure of the inner bag body is raised, and the inner bag body is unsealed by the internal pressure. The volatile agent sealed in the inner bag body flows out into the outer bag body by unsealing the inner bag body. The volatile drug that has flowed out into the outer bag is infiltrated with the micropores of the microporous sheet and exuded to the surface of the sheet, thereby volatilizing to the outside.

As a form of use of the drug volatilization container, a case where the drug volatilization bag is placed in the casing in a vertical state and a case where the drug volatilization bag is placed in the casing in a horizontal state may be employed. In particular, in the form of use of the drug volatilization container in which the drug volatilization bag is placed in the outer casing in a horizontal state, as described above, the agent is volatilized by placing one side of the outer bag body facing the upper side with the microporous sheet. The bag can suppress the infiltration of a plurality of micropores of the microporous sheet and the volatile agent which oozes out to the surface of the sheet to be dropped into the inside of the casing or the outside of the casing.

According to the present invention, at least one side of the outer bag system is composed of a plurality of microporous sheets having a plurality of micropores which are infiltrated by a volatile agent, and thus the microporous sheet is different from the prior gas permeable film, and it is not necessary to select and involve a plurality of chemistry. A combination of volatile chemicals of a nature can use a plurality of volatile agents, so that the volatile agent can be easily volatilized from the outer bag. As described above, since the microporous sheet constituting at least one side of the outer bag body is not limited to the volatile agent that can be used, the selective elasticity can be improved when the volatile agent is used. As a result, it is possible to realize a drug volatilization bag and a drug volatilization container which can easily and quickly correspond to various uses.

11‧‧‧Pharmaceutical volatile bag

12‧‧‧ inside pocket

13‧‧‧Outer bag

14‧‧‧Non-gas permeable film

15‧‧‧ volatile agents

16‧‧‧Edge

17‧‧‧Microporous flakes

18‧‧‧Sheet that cannot be infiltrated

19‧‧‧Edge

21‧‧‧ Shell

22‧‧‧pharmaceutical volatile container

23‧‧‧Shell half

24‧‧‧Shell half

25‧‧ ‧ sales

26‧‧‧ recessed hole

27‧‧‧ claws

28‧‧‧ claws

29‧‧‧ Pressing Department

30‧‧‧Connecting Department

31‧‧‧ openings

32‧‧‧Volatile holes

33‧‧‧Four Corners

34‧‧‧ pressed into the wall

35‧‧‧Support wall

36‧‧‧Location Limit Wall

37‧‧‧Receiving Department

38‧‧‧Support surface

39‧‧‧Inside circular wall

40‧‧‧Outer circular wall

41‧‧‧Cross-shaped wall

42‧‧‧Adhesive tape

43‧‧‧Dustbin

44‧‧‧Installed components (trash can cover)

45‧‧‧ pressing surface

Fig. 1 is an assembled, exploded perspective view showing a drug volatile bag in an embodiment of the present invention.

Fig. 2 is a perspective view showing the assembly end of the drug volatile bag of Fig. 1.

Figure 3 is a cross-sectional view taken along line A-A of Figure 2.

Fig. 4 is a cross-sectional view showing the state of use of the medicine volatile bag of Fig. 3.

Fig. 5 is a view showing the outer casing of the medicine volatilizing bag, (A) is a top view, (B) is a front view, and (C) is a lower surface view.

Figure 6 is a cross-sectional view taken along line B-B of Figure 5(A).

Figure 7 is a view showing the lower surface of the outer casing half of one side.

Figure 8 is a cross-sectional view taken along line C-C of Figure 7.

Figure 9 is a top plan view showing the outer casing half of the other side.

Figure 10 is a cross-sectional view taken along line D-D of Figure 9.

Fig. 11 is an exploded perspective view showing the assembly of a drug volatilization container including a casing and a drug volatilization bag.

Fig. 12 is an exploded perspective view showing the state in which the drug volatilizing bag is placed on the outer casing.

Fig. 13 is a perspective view showing the assembly end of the drug volatilization container including the outer casing and the drug volatile bag.

Figure 14 is a cross-sectional view showing the state in which the drug volatilization container is attached to the lid of the waste bin.

Figure 15 is an enlarged cross-sectional view of the essential part of Figure 14.

Figure 16 is a cross-sectional view showing the essentials of the inner bag of the unpacking medicament volatile bag.

Fig. 17 is an enlarged cross-sectional view showing an essential part of a state in which the inner bag of the drug volatilizing bag shown in Fig. 15 is unsealed.

Hereinafter, embodiments of the drug volatile bag of the present invention and a drug volatilization container containing the same will be described in detail. In the following embodiments, the fragrance of the garbage can is exemplified as being attached to the inside of the lid of the garbage can. However, in addition to the fragrance of the garbage can, it can also be used as a fragrance or deodorant in a room or a car. Apply it.

1 to 4 illustrate a medicament volatile bag 11, and FIG. 1 is an assembled exploded perspective view. Fig. 3 is a cross-sectional view taken along line A-A of Fig. 2, and Fig. 4 is a cross-sectional view showing a state of use. As shown in FIGS. 1 to 3, the drug volatilizing bag 11 has a double structure including a soft inner bag body 12 and a soft outer bag body 13 for accommodating the inner bag body 12. In addition, in FIGS. 3 and 4, the thickness and internal space of the inner bag body 12 and the outer bag body 13 are exaggerated.

The inner bag body 12 having a rectangular shape in plan view is formed into a bag shape by a transparent non-gas permeable film 14, and a volatile drug 15 is sealed inside. The non-gas permeable film 14 which is a material of the inner bag body 12 has a thermoplastic synthetic resin containing, for example, polyester, polyamide, ethylene-vinyl acetate copolymer saponified product, denatured polyvinyl alcohol, polyvinylidene chloride or the like. Or a multilayered material of one or more of metal foils such as aluminum. Further, as the volatile agent 15, a solvent containing a volatile fragrance is used, and for example, an alkane hydrocarbon, a glycol ether, an ethylene glycol, an alcohol, an ester, a ketone, a lactone, an aldehyde or the like can be used. Further, the volatile agent is not limited to a liquid, and may be a solid, a gel, a sol, or a mixture thereof. When the volatile drug 15 is colored in advance, since the inner bag 12 is formed of the transparent film 14, it is easy to visually confirm the volatile drug 15 from the outside. Further, the volatile agent 15 may also have viscosity by a tackifier. Examples of the tackifier include glycerin, sugar fatty acid esters, waxes, polysaccharides, carrageenan, minerals, metal soaps, long-chain fatty acids, polyvalent metal salts of long-chain fatty acids, amino acid derivatives, and sugar derivatives. Wait.

The inner bag body 12 is formed by folding a piece of the non-gas permeable film 14 in half and thermally fusing the three side portions 16 of the opening to form a bag shape. The three side portions 16 are sealed by a strength that can be unsealed by raising an internal pressure by an external force. In this case, the number and location of the side portions 16 sealed in a detachable manner are arbitrary. Further, in the inner bag body 12, one piece of the non-gas permeable film 14 is folded in half and the three side portions 16 are sealed by detachable sealing, but the two non-gas permeable films 14 may be overlapped. In the case of a bag, in this case, the number and location of the side portions 16 which are sealed in a detachable manner are also arbitrary.

Further, the outer bag body 13 having a rectangular shape in plan view is formed by superposing one of the microporous sheets 17 constituting one surface and the one transparent sheet 18 constituting the other surface opposite thereto, and is heated. The four side portions 19 of the opening are heat-sealed to form a bag shape. Further, the microporous sheet 17 may constitute one of the faces in addition to the entire surface of one of the outer bag bodies 13. The four side portions 19 of the outer bag body 13 are different from the case of the inner bag body 12, and are sealed so as not to be unsealed by an increase in internal pressure caused by an external force. By forming the other side of the outer bag body 13 with the transparent sheet 18, the inner bag body 12 and the volatile drug 15 can be easily visually confirmed from the other side. Further, in this embodiment, the case where the other side of the outer bag body 13 is formed by the transparent sheet 18 will be described. However, the sheet constituting the other side of the outer bag body 13 does not necessarily have to be transparent, and may be non-transparent or translucent. It can also be a microporous sheet.

The microporous sheet 17 constituting one surface of the outer bag body 13 has a plurality of micropores which can infiltrate the volatile agent 15. That is, unlike the gas permeable film through which the gas of the volatile drug 15 is transmitted, a plurality of micropores are physically formed to the extent that the volatile drug 15 is wetted and oozes out to the surface of the sheet. Examples of the microporous sheet 17 include various polyethylenes such as high density polyethylene, medium density polyethylene, low density polyethylene, linear low density polyethylene, and ultrahigh molecular weight polyethylene, or ethylene vinyl acetate. Copolymer and saponified product thereof, ethylene-acrylic copolymer, ethylene-propylene copolymer, various olefin resins and copolymers thereof, diene resins and copolymers thereof, polyethylene terephthalate, polyparaphenylene Butane dicarboxylate, polycarbonate, polystyrene, polyvinyl chloride, polyvinylidene chloride, polycarbonate, polyurethane, various acrylic resins, polyvinyl alcohol, polyimine, fluororesin, oxime resin, ring A semi-synthetic resin such as an oxygen resin or a celecin. The resin used for the microporous sheet 17 may be used singly or as a copolymer, a mixture or the like. Further, a multilayer sheet formed into a plurality of layers using a plurality of the above resins may also be used. In order to form a multilayer sheet, it is carried out by a conventional method such as dry lamination or co-extrusion, extrusion lamination, and the like. It is also possible to knead various additives when forming into a sheet, and perform stretching or heat treatment after molding. Coating, vapor deposition, and the like may also be performed after molding. When the sheet is two or more layers, one of the layers may be a metal foil or a metal deposition film or an inorganic vapor deposition film layer.

The transparent sheet 18 constituting the other side of the outer bag body 13 is incapable of infiltrating the volatile agent 15 sheets. That is, unlike the microporous sheet 17, the volatile agent 15 is not wetted. The transparent sheet 18 which is not impregnated with the volatile agent 15 may be any one of a gas permeable film that transmits a gas of the volatile agent 15 at a molecular level or a non-gas permeable film that blocks a gas of the volatile agent 15. . As the non-gas permeable film, any material that can be selected from the inner bag body 12 can be used. Further, as the gas permeable film, for example, a thermoplastic resin containing polyethylene, polypropylene, ethylene-vinyl acetate copolymer resin, ionic polymer resin, ethylene-acrylic copolymer resin, or ethylene-α olefin copolymer resin may be used. Multilayer laminate material above.

In the drug volatilizing bag 11 including the above-described configuration, as shown in FIG. 4, the internal pressure of the inner bag body 12 is raised by the action of an external force (see the white arrow in the drawing), so that the three side portions 16 of the seal are sealed. When the inner bag body 12 is unsealed and the inner bag body 12 is unsealed, the volatile drug 15 sealed in the inner bag body 12 flows out into the outer bag body 13. The outer bag body 13 is composed of a microporous sheet 17 having a plurality of micropores capable of infiltrating the volatile agent 15 on one side (upper surface in the drawing), so that the volatile agent 15 flowing out into the outer bag body 13 is infiltrated. The micropores of the microporous sheet 17 are exuded to the surface of the sheet, thereby volatilizing to the outside (see the dotted arrow in the drawing).

In this manner, since the microporous sheet 17 constituting one surface of the outer bag body 13 is formed by infiltrating the volatile agent 15 and oozing out to the surface of the sheet, a plurality of micropores are physically formed, which is different from the conventional gas permeable film. It is not necessary to select a combination with the volatile agent 15 involving a plurality of chemical properties, and a plurality of volatile agents 15 can be used to easily volatilize the volatile agent 15 from the outer bag body 13. As described above, since the volatile drug 15 which can be used is not limited to the microporous sheet 17 constituting one surface of the outer bag body 13, the selective elasticity can be improved when the volatile drug 15 is used.

Since the microporous sheet 17 is oozing to the surface of the sheet by infiltrating the volatile agent 15 with a plurality of micropores, the volatile amount of the volatile agent 15 is also increased as compared with the gas permeable sheet, and the volatile agent 15 can be obtained. The outer bag 13 is well volatilized. Therefore, it is not necessary to form the both sides of the outer bag body 13 with the microporous sheet 15, and the microporous sheet only constitutes the outer side. One side of the bag body 13 is sufficient. As a result, the other surface of the outer bag body 13 may be formed of a sheet such as a gas permeable film or a non-gas permeable film that the volatile agent 15 cannot wet.

In the case where the chemical vapor-deposited bag 11 described above is used as the fragrance of the garbage can, the drug volatile bag 11 is stored in a drug volatilization container of the resin-made outer casing 21 such as plastic. 5 to 10 illustrate the outer casing 21, and FIG. 5 illustrates the outer casing 21 in which the two outer casing halves 23, 24 are butted together, (A) is a top view, (B) is a front view, and (C) is a front view. Bottom view, Fig. 6 is a cross-sectional view taken along line BB of Fig. 5(A), and Fig. 7 is a bottom view of the outer casing half 23 (hereinafter referred to as the upper casing), and Fig. 8 is taken along line CC of Fig. 7. In the cross-sectional view, Fig. 9 is a top view of the outer casing half 24 (hereinafter referred to as the lower casing) on the other side, and Fig. 10 is a sectional view taken along line DD of Fig. 9.

As shown in Figs. 5(A) to 5(C) and Fig. 6, the outer casing 21 has a two-divided structure in which two disc-shaped upper and lower casings 23 and 24 are butted together. The outer casing 21 is provided with a replaceable and used chemical volatile bag 11 in the outer peripheral portion of the outer casing 23 shown in Figs. 7 and 8 and the outer casing 24 shown in Figs. 9 and 10; The structure is as follows. The insertion of the pin 25 of the upper casing 23 into the recessed hole 26 of the lower casing 24 allows the upper and lower casings 23, 24 to be aligned, and by hooking the claws 27 of the upper casing 23 and the claws 28 of the lower casing 24, The upper and lower casings 23 and 24 have a fitting structure that can be separated by one touch. In the outer casing 21, a fitting structure in which the claws 27 and 28 are hooked and fastened to each other is used. However, the outer casing 21 can be opened and closed by a hinge structure, whereby the used chemical volatile bag 11 can be replaced.

In the upper casing 23, a circular pressing portion 29 for imparting an external force to the outer bag body 13 via the inner bag body 12 of the drug volatilizing bag 11 is provided at a central portion thereof. The pressing portion 29 is integrally formed in a state of being supported by the upper casing 23 via the flexible connecting portion 30, and is disposed in the opening portion 31 of the upper casing 23 so as to be press-fitted. Around the circumferential direction of the pressing portion 29, a plurality of volatilization holes 32 for discharging the chemical gas of the volatile drug 15 are used. Further, a portion of the upper casing 23 corresponding to the four corner portions 33 of the outer bag body 13 is integrally formed. There are four press-in wall sheets 34 which are positioned to be placed on the four corners 33 of the bag body 13 on the outer side of the drug volatilization bag 11 of the lower outer casing 24 when the upper and lower outer casings 23, 24 are butted. FIG. 9) is pressed inwardly toward the inner side of the outer casing 24.

The lower support case 24 is integrally provided with four support wall pieces 35 on which the bag body 13 on the outer side of the drug volatilization bag 11 is placed. Further, four position regulating wall pieces 36 for restricting the position of the outer bag body 13 by abutting against the side portions 19 of the outer bag body 13 are integrally provided. The front end portion of the position regulating wall piece 36 is hook-shaped, and the hook-shaped front end portion is pressed into the outer bag body 13, thereby preventing the outer bag body 13 from floating, thereby stabilizing the positional restriction. A receiving portion 37 is integrally formed at a central portion of the lower casing 24, and the receiving portion 37 supports the inner bag body 12 of the drug volatilizing bag 11 that is externally biased by the pressing portion 29 via the outer bag body 13. The receiving portion 37 has a support surface 38 that is inclined so as to face the pressing portion 29 that is subjected to the pressing operation by interposing the drug volatile bag 11. The receiving portion 37 is formed into a double structure of the inner circular wall piece 39 and the outer circular wall piece 40, and the supporting surface 38 is formed by the inner circular plate 39 and the inner cruciform wall piece 41 and the outer circular wall piece. The upper end of 40 is formed.

Further, an adhesive tape 42 for attaching the drug volatilization container 22 to the inside of the lid of the garbage can is provided at a central portion on the outer side of the lower casing 24. The lower casing 24 is not provided with a volatilization hole 32. Since the lower casing 24 is provided with an adhesive tape 42 for attaching the drug volatilization container 22 to the inside of the lid of the garbage can, the volatilization hole 32 is not provided in the lower casing 24, thereby preventing the volatilization of the volatilized bag 11 from volatilization during use. The medicament 15 lowers the adhesive force of the adhesive tape 42 disposed in the lower outer casing 24 or the material of the cover of the waste bin.

The method of loading the above-described drug volatile bag 11 to the above-described outer casing 21 will be described in detail below with reference to Figs. 11 to 13 . Fig. 11 to Fig. 13 are diagrams showing the drug volatilization container 22 in which the drug volatilizing bag 11 is placed in the above-described outer casing 21, and Fig. 11 and Fig. 12 are assembled and exploded perspective views, and Fig. 13 is an assembled end perspective view.

On the support wall piece 35 of the lower outer casing 24, a rectangular drug volatile bag 11 is placed such that the microporous sheet 17 of the bag body 13 on the outer side of the drug volatilizing bag 11 faces the lower casing 24 side, and The side portions 19 of the drug volatilizing bag 11 are brought into contact with the position regulating wall piece 36 from the side, thereby positioning the drug volatilizing bag 11. The outer casing 24 is placed on the lower surface of the medicament volatile bag 11, and the outer casing is positioned to include the pin 25 of the upper casing 23 and the recess 26 of the lower casing 24, and the claws 27 of the upper casing 23 and the claws of the lower casing 24 28 hooks and buckles are constructed to fit. In this way, the assembly of the drug volatilizing bag 11 to the outer casing 21 is completed.

When the upper and lower outer casings 23 and 24 are butted, the four corner portions 33 of the outer bag body 13 positioned on the outer side of the drug volatilizing bag 11 placed on the lower outer casing 24 are located on or near the outer periphery of the upper and lower outer casings 23 and 24 (refer to FIG. 9). Therefore, there is a possibility of biting into or between the outer peripheral portions of the upper and lower outer casings 23, 24. Therefore, the four corner portions 33 of the outer bag body 13 of the drug volatile bag 11 are pressed toward the inner side of the lower casing 24 by the press-fit wall sheets 34 provided on the upper casing 23 when the upper and lower casings 23 and 24 are butted. Thereby, the four corner portions 33 of the outer bag body 13 of the preventive agent volatilizing bag 11 are snapped between the outer peripheral portions of the upper and lower outer casings 23, 24, or protrude from the outer peripheral portion thereof, and the bite or the outer bag body is prevented from being formed. 13 is broken to cause the volatile agent 15 to leak to the outside.

When the above-described chemical vaporization container 22 is used as the fragrance of the garbage can, as shown in FIGS. 14 and 15, the drug volatilization container 22 is attached to the member to be mounted by the adhesive tape 42 provided on the lower case 24. That is, the inside of the lid 44 of the waste bin 43. That is, the drug volatilization container 22 is attached in a state in which the outer casing 23 is downward and the lower casing 24 is upward and downward. In the mounted state, the drug volatilization container 22 is maintained in a substantially horizontal state, and the drug volatilization bag 11 accommodated in the drug volatilization container 22 is held in a state in which the microporous sheet 17 is directed upward. On the other hand, before or after the drug volatilization container 22 is attached to the lid 44 of the waste bin 43, the inner bag body 12 of the drug volatilization bag 11 is unsealed by the following operation.

First, by pressing the pressing portion 29 provided on the upper portion 23 of the drug volatilization container 22 toward the inside of the container, the outer bag body 13 is placed outside the drug volatilizing bag 11 to apply an external force to the inner bag body 12. The internal pressure of the inner bag body 12 is increased by the application of the external force, and the inner bag body 12 is unsealed by the internal pressure. Since the three side portions 16 of the inner bag body 12 are sealed by the strength of the detachable seal which can be increased by the external force, the inner bag body 12 is unsealed by the three side portions 16 Part or all of the opening is performed.

When the external force is applied to the pressing portion 29, as shown in FIG. 16, the pressing portion 29 provided in the upper casing 23 via the connecting portion 30 is flexible by the connecting portion 30, so that the connecting portion 30 is deflected. Press into the inside of the container. By the press-fitting operation of the pressing portion 29, the drug volatile bag 11 is sandwiched between the receiving portion 37 of the lower casing 24 and the pressing portion 29. The pressing portion 29 which is inclined by the press-fitting operation is provided with a supporting surface 38 including the inner circular wall piece 39 and the cross-shaped wall piece 41 and the receiving portion 37 of the outer circular wall piece 40 to partition the medicine volatile bag. Since the pressing surface 45 of the pressing portion 29 is parallel to the supporting surface 38 of the receiving portion 37, the pressing portion 29 is in contact with the drug evolving bag 11 at all times.

In this way, since the contact area between the pressing portion 29 and the medicine volatile bag 11 can be ensured to the utmost extent, a sufficient external force can be applied by the pressing portion 29, and the inner bag body 12 of the drug volatilizing bag 11 can be reliably unsealed. Further, the inner bag body 12 can be detachably sealed by a simple structure including the pressing portion 29 of the upper casing 23 and the receiving portion 37 of the lower casing 24 and the outer casing 21 disposed outside the drug volatile bag 11.

By unsealing the inner bag body 12, as shown in Fig. 17, the volatile drug 15 sealed in the inner bag body 12 flows out into the outer bag body 13. The outer bag body 13 is formed to face one side of the upper side by a microporous sheet 17 having a plurality of micropores capable of infiltrating the volatile agent 15, so that the volatile agent 15 flowing out into the outer bag body 13 is a microporous sheet. The micropores of 17 are infiltrated and exuded to the surface of the sheet, thereby volatilizing to the outside. The volatile drug 15 volatilized to the outside of the outer bag body 13 is discharged to the outside of the container through the volatilization hole 32 and the opening 31 provided in the upper casing 23 of the drug volatilization container 22. As described above, the volatile agent 15 volatilized outside the container is filled in the inside of the garbage can 43, and the drug volatilization container 22 functions as a fragrance of the garbage can 43.

Further, when the volatile drug 15 enclosed in the inner bag body 12 of the drug volatile bag 11 is colored in advance, the transparent sheet 18 is formed to face the outer bag 23 side of the outer bag body 13, so that it can be volatilized from the upper case 23 The hole 32 and the opening portion 31 visually see the volatile drug flowing out to the outer bag body 13 The agent 15 is thus easy to confirm the remaining amount of the volatile agent 15. As a result, when the drug volatilization container 22 is discarded, the disposal time of the drug volatilization container 22 can be quickly and easily recognized. Further, in the case where the drug volatilization container 22 can be replaced, the replacement period of the drug volatilization bag 11 can be quickly and easily recognized.

Further, since the drug volatile bag 11 is composed of the soft inner bag body 12 and the outer bag body 13, even if the volatile agent 15 is reduced by the volatilization of the volatile drug 15, the volatile agent 15 can be reduced. The microporous sheet 17 of the outer bag body 13 is in close contact with the volatile drug 15 by internal pressure reduction. In this manner, the air layer cannot be formed between the microporous sheet 17 and the volatile agent 15 , so that the microporous sheet 17 is always in contact with the volatile agent 15 , so that the volatile agent 15 is exhausted until the volatile agent 15 is exhausted. The microporous sheet 17 is infiltrated and penetrates the surface of the sheet, so that the volatile agent 15 can be prevented from remaining in the drug volatile bag 11 without being reduced.

In the use form of the drug volatilization container 22 described above, the fragrance of the waste container 43 is held in a state in which the drug volatile bag 11 is held inside the lid 44 of the waste bin 43 in a horizontal state, that is, a so-called transverse state. As described above, in the form of use of the drug volatilization container 22 in which the drug volatilization bag 11 is placed in the outer casing 21 in a horizontal state, as described above, one of the outer bag members 13 is formed by the microporous sheet 17 When the drug volatilization bag 11 is placed on the upper side, it is possible to suppress the infiltration of the plurality of micropores of the microporous sheet 17 and the volatile drug 15 that has permeated the surface of the sheet to be dripped from the inside of the casing or the outside of the casing.

In the above embodiment, the use of the drug volatilization container 22 in which the drug volatilization bag 11 is placed in the outer casing 21 in a horizontal state is described. However, the present invention is not limited thereto, and the drug volatilization bag may be used. 11 The use form of the drug volatilization container disposed in the outer casing in a vertical state. In this case, even if the plurality of micropores of the microporous sheet 17 are wetted and the volatile agent 15 that has permeated the surface of the sheet becomes a droplet, it is possible to suppress dripping from the outside of the outer casing by receiving the droplet with the outer casing. .

The present invention is not limited to the above embodiments, and does not deviate from the gist of the present invention. It is a matter of course that the scope of the invention is to be construed as being limited by the scope of the invention and the scope of the invention is intended to be

11‧‧‧Pharmaceutical volatile bag

12‧‧‧ inside pocket

13‧‧‧Outer bag

14‧‧‧Non-gas permeable film

15‧‧‧ volatile agents

16‧‧‧Edge

17‧‧‧Microporous flakes

18‧‧‧Sheet that cannot be infiltrated

Claims (4)

A medicine volatile bag comprising: a soft inner bag body formed of a non-gas permeable film and enclosing a volatile agent inside; and a soft outer side bag body accommodating the inner bag body; the inner bag The system is constructed by unpacking the internal pressure caused by an external force; the outer bag has one side and the other side opposite thereto, and at least the one side is microporous having a plurality of micropores for infiltrating the volatile agent. A thin sheet of material. The pharmaceutical volatile bag of claim 1, wherein the other side is formed of a sheet which is incapable of infiltrating the volatile agent. A medicine volatilization container characterized by comprising the drug volatilization bag and the outer casing of claim 1 or 2, wherein the outer casing accommodates the drug volatilization bag, and a portion corresponding to the inner bag body is provided with a space between the outer bag and the inner bag The body is provided with a pressing portion for external force. The drug volatilization container according to claim 3, wherein the outer casing is placed on the upper side of the outer bag and the chemical volatilization bag is placed, and the outer casing is attached to the member to be attached.